ChronoScale Holdings Statistics
Total Valuation
CHRN has a market cap or net worth of $1.99 billion. The enterprise value is $2.09 billion.
| Market Cap | 1.99B |
| Enterprise Value | 2.09B |
Important Dates
The next estimated earnings date is Thursday, November 19, 2026, before market open.
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CHRN has 145.64 million shares outstanding.
| Current Share Class | 145.64M |
| Shares Outstanding | 145.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.23% |
| Owned by Institutions (%) | 0.90% |
| Float | 4.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.67 |
| Forward PS | 14.27 |
| PB Ratio | 13.22 |
| P/TBV Ratio | 20.70 |
| P/FCF Ratio | 80.87 |
| P/OCF Ratio | 37.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 206.95, with an EV/FCF ratio of 84.76.
| EV / Earnings | n/a |
| EV / Sales | 21.67 |
| EV / EBITDA | 206.95 |
| EV / EBIT | n/a |
| EV / FCF | 84.76 |
Financial Position
The company has a current ratio of 0.30, with a Debt / Equity ratio of 0.74.
| Current Ratio | 0.30 |
| Quick Ratio | 0.23 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 3.22 |
| Debt / FCF | 4.51 |
| Interest Coverage | -6.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -26.31% |
| Weighted Average Cost of Capital (WACC) | 9.45% |
| Revenue Per Employee | $1.12M |
| Profits Per Employee | -$949,698 |
| Employee Count | 88 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +153.80% in the last 52 weeks. The beta is 0.98, so CHRN's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | +153.80% |
| 50-Day Moving Average | 18.22 |
| 200-Day Moving Average | 16.06 |
| Relative Strength Index (RSI) | 38.37 |
| Average Volume (20 Days) | 153,694 |
Short Selling Information
The latest short interest is 641,843, so 0.44% of the outstanding shares have been sold short.
| Short Interest | 641,843 |
| Short Previous Month | 576,571 |
| Short % of Shares Out | 0.44% |
| Short % of Float | 15.61% |
| Short Ratio (days to cover) | 4.78 |
Income Statement
In the last 12 months, CHRN had revenue of $96.37 million and -$81.67 million in losses. Loss per share was -$0.58.
| Revenue | 96.37M |
| Gross Profit | -14.08M |
| Operating Income | -51.10M |
| Pretax Income | -64.49M |
| Net Income | -81.67M |
| EBITDA | 10.09M |
| EBIT | -51.10M |
| Loss Per Share | -$0.58 |
Balance Sheet
The company has $15.22 million in cash and $111.06 million in debt, with a net cash position of -$95.84 million or -$0.66 per share.
| Cash & Cash Equivalents | 15.22M |
| Total Debt | 111.06M |
| Net Cash | -95.84M |
| Net Cash Per Share | -$0.66 |
| Equity (Book Value) | 150.65M |
| Book Value Per Share | 1.03 |
| Working Capital | -70.48M |
Cash Flow
In the last 12 months, operating cash flow was $53.60 million and capital expenditures -$28.96 million, giving a free cash flow of $24.64 million.
| Operating Cash Flow | 53.60M |
| Capital Expenditures | -28.96M |
| Depreciation & Amortization | 61.19M |
| Net Borrowing | -70.79M |
| Free Cash Flow | 24.64M |
| FCF Per Share | $0.17 |
Margins
Gross margin is -14.61%, with operating and profit margins of -53.03% and -84.63%.
| Gross Margin | -14.61% |
| Operating Margin | -53.03% |
| Pretax Margin | -66.92% |
| Profit Margin | -84.63% |
| EBITDA Margin | 10.47% |
| EBIT Margin | -53.03% |
| FCF Margin | 25.56% |
Dividends & Yields
CHRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -4.25% |
| FCF Yield | 1.24% |
Analyst Forecast
The average price target for CHRN is $28.50, which is 108.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.50 |
| Price Target Difference | 108.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 280.58% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
CHRN has an Altman Z-Score of 2.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.29 |
| Piotroski F-Score | 2 |